Delaware's Incyte partnering with Novartis to determine whether blockbuster drug Jakafi can aid seriously ill COVID-19 patients
Novartis plans to initiate a Phase III clinical trial in collaboration with Delaware-based Incyte to evaluate the use of Jakafi (Jakavi outside the United States) for the treatment…
